Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

NCT04594161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2024-02-28

No results posted yet for this study

Summary

To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis.

Conditions

  • Urolithiasis
  • Urologic Diseases
  • Urinary Calculi
  • Urinary Obstruction
  • Urinary Stone
  • Ureteric Obstruction
  • Calculus Ureteral
  • Stone Ureter
  • Stone;Renal
  • Stone, Kidney
  • Stone, Urinary
  • Obstruction Ureter
  • Obstruction
  • Ureter Calculi
  • Ureter Obstruction
  • Kidney Diseases
  • Kidney Calculi
  • Kidney Failure, Acute
  • Kidney Dysfunction
  • Kidney Insufficiency
  • Pyelonephritis
  • Pyelonephritis Acute
  • Pyelonephritis Obstructive
  • Pyelonephritis; Calculus
  • Pyelonephritis; Obstruction
  • Pyelonephrosis
  • Hydronephrosis
  • Hydronephrosis; Infection
  • Hydronephrosis, Infected
  • Hydronephrosis; Obstruction, Ureter
  • Hydronephrosis; Obstruction, Renal Calculus
  • Hydronephrosis, Secondary
  • Renal Pelvis; Obstruction

Interventions

DEVICE

Percutaneous Nephrostomy

A Percutaneous Nephrostomy will be placed in patients with obstructive urolithiasis

DEVICE

Double J catheter

A Double J catheter will be placed in patients with obstructive urolithiasis

Sponsors & Collaborators

  • Alrijne Hospital

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Ad Hendrikx, dr. · no affiliation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04594161 on ClinicalTrials.gov